共 50 条
- [1] Deferiprone versus deferoxamine for transfusional iron overload in sickle cell disease and other anemias: Pediatric subgroup analysis of the randomized, open-label FIRST studyPEDIATRIC BLOOD & CANCER, 2024, 71 (01)Hamdy, MonaEl-Beshlawy, AmalVerissimo, Monica P. A.Kanter, JulieInusa, BabaWilliams, SuzanLee, DavidTemin, Noemi ToiberFradette, CarolineTricta, FernandoEbeid, Fatma S. E.Kwiatkowski, Janet L.Elalfy, Mohsen S.
- [2] A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell diseaseBRITISH JOURNAL OF HAEMATOLOGY, 2007, 136 (03) : 501 - 508Vichinsky, ElliottOnyekwere, OnyinyePorter, JohnSwerdlow, PaulEckman, JamesLane, PeterFiles, BeatriceHassell, KathrynKelly, PatrickWilson, FeliciaBernaudin, FrancoiseForni, Gian LucaOkpala, IheanyiRessayre-Djaffer, CatherineAlberti, DanieleHolland, JaymesMarks, PeterFung, EllenFischer, RolandMueller, Brigitta U.Coates, Thomas
- [3] A Cost-Utility Analysis of Deferiprone Compared to Desferrioxamine and Deferasirox for the Treatment of Chronic Myocardial Iron Overload in Thalassemia PatientsBLOOD, 2015, 126 (23)Pepe, AlessiaHanif, AishahBentley, AnthonyWalker, RoderickFrizziero, LudovicaPutti, Maria CaterinaSpasiano, AnnaBorgna-Pignatti, CaterinaMaggio, AurelioNeri, Maria GiovannaMeloni, Antonella
- [4] Deferiprone for transfusional iron overload in sickle cell disease and other anemias: open-label study of up to 3 yearsBLOOD ADVANCES, 2023, 7 (04) : 611 - 619Elalfy, Mohsen S.Hamdy, MonaEl-Beshlawy, AmalEbeid, Fatma S. E.Badr, MohamedKanter, JulieInusa, BabaAdly, Amira A. M.Williams, SuzanKilinc, YurdanurLee, DavidFradette, CarolineRozova, AnnaTemin, Noemi ToiberTricta, FernandoKwiatkowski, Janet L.
- [6] Randomized Controlled Trial of the Efficacy and Safety of Deferiprone in Iron-Overloaded Patients with Sickle Cell Disease or Other AnemiasBLOOD, 2019, 134Kwiatkowski, Janet L.Elalfy, Mohsen SalehFradette, CarolineHamdy, MonaEl-Beshlawy, AmalEbeid, Fatma Soliman ElsayedVerissimo, Monica Pinheiro De AlmeidaBadr, Mohamed AhmedAbdulrahman, AlshehriKanter, JulieInusa, Baba P. D.Bejaoui, MohamedWilliams, SuzanKilinc, YurdanurTsang, Yu-ChungStilman, AnneRozova, AnnaSinclair, JodieShaw, DianChan, TheresaTemin, Noemi ToiberLee, DavidSpino, MichaelTricta, Fernando
- [7] LONG-TERM EFFICACY AND SAFETY OF DEFERIPRONE FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANEMIASPEDIATRIC BLOOD & CANCER, 2021, 68 : S14 - S14Elalfy, MohsenHamdy, MonaEl-Beshlawy, AmalEbeid, FatmaBadr, MohammedKanter, JulieInusa, BabaWilliams, SuzanLee, DavidTricta, FernandoKwiatkowski, Janet L.
- [8] Cost-effectiveness Analysis of Deferiprone and Deferasirox on Thalassemia Major Patients in Tangerang District Hospital, IndonesiaJOURNAL OF YOUNG PHARMACISTS, 2018, 10 (02) : S128 - S131Chairunnisa, Hana GhinaSauriasari, RaniRizkyani, Nanda Asyura
- [9] Randomized Controlled Trial of the Efficacy and Safety of Deferiprone: Subgroup Analysis of Pediatric Patients in Iron-Overloaded Patients with Sickle Cell Disease and Other AnemiasBLOOD, 2021, 138Hamdy, MonaEl-Beshlawy, AmalEbeid, Fatma Soliman ElsayedKwiatkowski, Janet L.Kanter, JulieInusa, Baba P. D.Williams, SuzanLee, DavidTemin, Noemi T.Fradette, CarolineTricta, FernandoElalfy, Mohsen Saleh
- [10] A COST-UTILITY ANALYSIS OF DEFERIPRONE COMPARED TO DESFERRIOXAMINE AND DEFERASIROX FOR THE TREATMENT OF CHRONIC IRON OVERLOAD IN PEOPLE WITH THALASSAEMIA: AN ITALIAN ADAPTATION OF THE UK MODELHAEMATOLOGICA, 2015, 100 : 150 - 150Meloni, A.Neri, M. G.Bentley, A.Hanif, A.Pepe, A.